These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24118902)

  • 1. Role of platelets in inflammation and cancer: novel therapeutic strategies.
    Dovizio M; Alberti S; Guillem-Llobat P; Patrignani P
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):118-27. PubMed ID: 24118902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets, cyclooxygenases, and colon cancer.
    Guillem-Llobat P; Dovizio M; Alberti S; Bruno A; Patrignani P
    Semin Oncol; 2014 Jun; 41(3):385-96. PubMed ID: 25023354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
    Evangelista V; Manarini S; Di Santo A; Capone ML; Ricciotti E; Di Francesco L; Tacconelli S; Sacchetti A; D'Angelo S; Scilimati A; Sciulli MG; Patrignani P
    Circ Res; 2006 Mar; 98(5):593-5. PubMed ID: 16484611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets: pleiotropic roles in atherogenesis and atherothrombosis.
    Linden MD; Jackson DE
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1762-6. PubMed ID: 20673808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet activation in obesity and metabolic syndrome.
    Santilli F; Vazzana N; Liani R; Guagnano MT; Davì G
    Obes Rev; 2012 Jan; 13(1):27-42. PubMed ID: 21917110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
    Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F
    Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin resistance.
    Tantry US; Mahla E; Gurbel PA
    Prog Cardiovasc Dis; 2009; 52(2):141-52. PubMed ID: 19732606
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of urinary 11-dehydro-thromboxane B
    Simeone P; Boccatonda A; Liani R; Santilli F
    Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
    Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse.
    Totani L; Dell'Elba G; Martelli N; Di Santo A; Piccoli A; Amore C; Evangelista V
    Thromb Haemost; 2012 Jun; 107(6):1130-40. PubMed ID: 22436970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance: is this term meaningful?
    Violi F; Pignatelli P
    Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-mediated inflammation in cardiovascular disease. Potential role of platelet-endothelium interactions.
    Tsoumani ME; Kalantzi KI; Goudevenos IA; Tselepis AD
    Curr Vasc Pharmacol; 2012 Sep; 10(5):539-49. PubMed ID: 22338568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.